Annual Cash & Cash Equivalents
$6.50 M
-$5.49 M-45.80%
December 31, 2024
Summary
- As of March 13, 2025, REVBW annual cash & cash equivalents is $6.50 million, with the most recent change of -$5.49 million (-45.80%) on December 31, 2024.
- During the last 3 years, REVBW annual cash & cash equivalents has risen by +$5.22 million (+409.84%).
- REVBW annual cash & cash equivalents is now -45.80% below its all-time high of $11.99 million, reached on December 31, 2023.
Performance
REVBW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.50 M
-$42.03 K-0.64%
December 31, 2024
Summary
- As of March 13, 2025, REVBW quarterly cash and cash equivalents is $6.50 million, with the most recent change of -$42.03 thousand (-0.64%) on December 31, 2024.
- Over the past year, REVBW quarterly cash and cash equivalents has dropped by -$42.03 thousand (-0.64%).
- REVBW quarterly cash and cash equivalents is now -55.34% below its all-time high of $14.55 million, reached on March 31, 2024.
Performance
REVBW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
REVBW Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.8% | -0.6% |
| 3 y3 years | +409.8% | -0.6% |
| 5 y5 years | +44.7% | -0.6% |
REVBW Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.8% | +409.8% | -55.3% | +409.8% |
| 5 y | 5-year | -45.8% | +409.8% | -55.3% | +409.8% |
| alltime | all time | -45.8% | +409.8% | -55.3% | +409.8% |
Revelation Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $6.50 M(-45.8%) | $6.50 M(-0.6%) |
| Sep 2024 | - | $6.54 M(-45.8%) |
| Jun 2024 | - | $12.07 M(-17.0%) |
| Mar 2024 | - | $14.55 M(+21.3%) |
| Dec 2023 | $11.99 M(+128.3%) | $11.99 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $5.25 M(+312.1%) | - |
| Jun 2022 | - | $3.48 M(-51.6%) |
| Mar 2022 | - | $7.19 M(+463.7%) |
| Dec 2021 | $1.27 M(-71.6%) | $1.27 M(-69.2%) |
| Sep 2021 | - | $4.14 M |
| Dec 2020 | $4.49 M | - |
FAQ
- What is Revelation Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Revelation Biosciences?
- What is Revelation Biosciences annual cash & cash equivalents year-on-year change?
- What is Revelation Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Revelation Biosciences?
- What is Revelation Biosciences quarterly cash and cash equivalents year-on-year change?
What is Revelation Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of REVBW is $6.50 M
What is the all time high annual cash & cash equivalents for Revelation Biosciences?
Revelation Biosciences all-time high annual cash & cash equivalents is $11.99 M
What is Revelation Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, REVBW annual cash & cash equivalents has changed by -$5.49 M (-45.80%)
What is Revelation Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of REVBW is $6.50 M
What is the all time high quarterly cash and cash equivalents for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash and cash equivalents is $14.55 M
What is Revelation Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, REVBW quarterly cash and cash equivalents has changed by -$42.03 K (-0.64%)